Fig. 4From: A Design of Experiment (DoE) based approach for development and optimization of nanosuspensions of telmisartan, a BCS class II antihypertensive drugCumulative percentage release of drug from formulations F1 to F5. Values were expressed mean ± SD, n = 6Back to article page